Literature DB >> 7733926

Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages.

M Sedqi1, S Roy, S Ramakrishnan, R Elde, H H Loh.   

Abstract

Treatment with opioid agonists in vitro and in vivo has been shown to affect the function of the immune system. Several investigators have suggested that immune cells may express opioid receptors, but it had been very difficult to demonstrate their presence on these cells by direct binding assays. Our earlier studies have shown that macrophage progenitor cells are highly sensitive to morphine treatment in vitro and in vivo. In the current investigation, we determined, unequivocally, the expression of mu-opioid receptor related transcripts in rat peritoneal macrophages by reverse transcriptase-polymerase chain reaction (RT-PCR) studies. In order to further characterize the transcript, the RT-PCR product was cloned and sequenced. The sequence analyses indicate that the transcripts from rat peritoneal macrophages are identical to those for the mu-opioid receptor described in the rat brain. To further confirm the presence of mu-opioid receptors, immunoreactivity to an antiserum raised against the carboxyl terminal fifteen amino acid residues of the mu-opioid receptor was determined. These studies show for the first time that rat peritoneal macrophages express a mu-opioid receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733926     DOI: 10.1006/bbrc.1995.1538

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Detection and function of opioid receptors on cells from the immune system.

Authors:  J M Bidlack
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

Review 2.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

Review 3.  Opioid receptors and signaling on cells from the immune system.

Authors:  Jean M Bidlack; Maxim Khimich; Amy L Parkhill; Sarah Sumagin; Baoyong Sun; Christopher M Tipton
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-08       Impact factor: 4.147

Review 4.  Effects of opioids on the immune system.

Authors:  S Roy; H H Loh
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

5.  Characterization of ionotropic glutamate receptors in human lymphocytes.

Authors:  G Lombardi; C Dianzani; G Miglio; P L Canonico; R Fantozzi
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

6.  Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.

Authors:  Chang-Jiang Guo; Yuan Li; Sha Tian; Xu Wang; Steven D Douglas; Wen-Zhe Ho
Journal:  J Investig Med       Date:  2002-11       Impact factor: 2.895

Review 7.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

8.  Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain.

Authors:  Imre Szabo; Xiao-Hong Chen; Li Xin; Martin W Adler; O M Z Howard; Joost J Oppenheim; Thomas J Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-18       Impact factor: 11.205

9.  Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor.

Authors:  Matthew J Finley; Xiaohong Chen; Guiseppe Bardi; Penny Davey; Ellen B Geller; Lily Zhang; Martin W Adler; Thomas J Rogers
Journal:  J Neuroimmunol       Date:  2008-06-03       Impact factor: 3.478

10.  Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model.

Authors:  Sulie L Chang; Jose A Beltran; Shilpa Swarup
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.